Sharda Cropchem, incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 4281.41 Crore) operating in Pesticides/Agro Chemicals sector.

Sharda Cropchem Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 4715.37 Crore) operating in Pesticides/Agro Chemicals sector.

Sharda Cropchem Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 4750.56 Crore) operating in Pesticides/Agro Chemicals sector.

The scrip on Wednesday traded at Rs 533.65, up 0.88 per cent, but only after falling 24 per cent in the previous four sessions. Brokerage Prabhudas Lilladher said healthy revenue growth was offset by adverse margins.Seasoned investor Dolly Khanna owned 1,081,526 shares or 1.2 per cent stake in this company as of June 30.

Sharda Cropchem Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 4980.62 Crore) operating in Pesticides/Agro Chemicals sector.

As per the latest corporate shareholdings filed, Dolly Khanna publicly holds 24 stocks with a net worth of over Rs 535.5 crore, shows Trendlyne data. Top bets include Chennai Petroleum, Polyplex Corp, Sharda Cropchem and KCP.

The Nifty Mid-cap index declined nearly 13% in 2022, while the Nifty Small-cap fell 25%. Earnings estimates by analysts saw net downgrades in June, marking the seventh consecutive month when next years estimates have been cut.

The Nifty Auto index closed 0.01 per cent up at 11116.3.

In the Nifty pack, 17 stocks were trading in the green, while 33 stocks were trading in the red.

The Nifty Bank index was trading 0.15 per cent up at 34300.0.

The Nifty Auto index was trading 0.2 per cent up at 11137.05.

Analysts said margins for the quarter fell mainly due to higher freight costs as they offered a favorable view on the stock with price targets in Rs 750-916 range, suggesting a 6-29 per cent potential upside on the counter. Sharda Cropchem deals in two segments - agrochemical and non-agrochemical.

Khanna entered Sharda Cropchem and held 1,243,710 shares or 1.38 per cent stake in the company as of March 31. Her name was not among key public shareholders in the previous quarter. The scrip has already gained 130 per cent in the last one year.

“I would be sticking out for some constant compounders like Divis Lab in the pharma space which posted fabulous numbers. Here valuation also fits the bill. There is also value proposition in midcaps in the agri space like Sharda Cropchem. With a buyback in place, TCS is a special situation trade which we are recommending to our investors.”

Management has guided to 20% volume growth in the coming two years with 20-24% EBITDA margins.